Home
About
Overview
Sharing Data
ORCID
Help
History (123)
Report from the NASPGN Therapeutics Subcommittee. Report of the activities of the gastrointestinal advisory committee to the FDA.
Gonadal Dysgenesis, 46,XX
Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial.
Challenges in cryopreservation of regulatory T cells (Tregs) for clinical therapeutic applications.
The RETRIEVE trial: safety and effectiveness of the retrievable crux vena cava filter.
See All 123 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The RETRIEVE trial: safety and effectiveness of the retrievable crux vena cava filter.
The RETRIEVE trial: safety and effectiveness of the retrievable crux vena cava filter. J Vasc Interv Radiol. 2013 May; 24(5):609-21.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Comorbidity
Device Removal
Female
Foreign Bodies
Humans
Incidence
Male
Middle Aged
Postoperative Complications
Pulmonary Embolism
Risk Assessment
Treatment Outcome
United States
Vena Cava Filters
Venous Thrombosis
Young Adult
authors with profiles
Thuong Van Ha